Antineuronal antibody status and phenotype analysis in Tourette's syndrome
✍ Scribed by Davide Martino; Giovanni Defazio; Andrew J. Church; Russell C. Dale; Gavin Giovannoni; Mary M. Robertson; Michael Orth
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 67 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The Gilles de la Tourette syndrome (GTS) spectrum includes psychiatric comorbidities, mainly obsessive–compulsive disorder (OCD) and attention‐deficit‐hyperactivity disorder (ADHD). The role of environmental factors, e.g., antineuronal antibodies (ANeA), remains unclear. We compared the clinical features of ANeA‐positive and ANeA‐negative patients in 53 children and 75 adults with GTS. All diagnoses were made according to DSM‐IV‐TR criteria. A positive ANeA Western immunoblot showed bands for at least 1 of 3 reported striatal antigens (40, 45, and 60 kDa). Twelve children (23%) and 18 adults (25%) with GTS were ANeA‐positive. Disease duration, tic phenomenology and severity, frequency of echo/pali/coprophenomena, self‐injurious and aggressive behavior, or frequency of OCD comorbidity did not significantly differ between ANeA‐positive and negative patients. Similar findings were obtained analyzing separately the three different antibody reactivities. A comorbid diagnosis of ADHD was significantly less frequent in GTS patients positive for the anti‐60 kDa antibody only. Using a multivariate logistic regression model, adjusting for age, gender, and age at disease onset, a comorbid diagnosis of ADHD remained inversely associated with anti‐60 kDa antibodies (odds ratio = 0.14; P = 0.002; 95% confidence interval 0.04–0.49). ANeA status does not differentiate a specific phenotype of GTS. © 2007 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract ## Background Opsoclonus‐myoclonus‐ataxia (OMA) is a paraneoplastic neurologic syndrome affecting 2–3% of children with neuroblastoma. Although children with OMA and neuroblastoma may have higher survival, many experience a significant amount of late neurologic impairment, which may be
## Abstract Comings et al. [1991: JAMA 266: 1793–1800] have recently reported a highly significant association between Tourette's syndrome (TS) and a restriction fragment length polymorphism (RFLP) of the dopamine D~2~ receptor gene (DRD2) locus. The A1 allele of the DRD2 __Taq__ I RFLP was present